The PE Ratio as of December 2025 (TTM) for Genetics Generation Advancement Corp. (4160.TWO) is 101.73

According to Genetics Generation Advancement Corp.’s latest financial reports and current stock price. The company's current PE Ratio is 101.73. This represents a change of 3.80% compared to the average of 98.01 of the last 4 quarters.

Genetics Generation Advancement Corp. (4160.TWO) Historical PE Ratio (quarterly & annually)

How has 4160.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Genetics Generation Advancement Corp. over the last ten years is 27.84. The current 101.73 PE Ratio has changed 36.44% with respect to the historical average. Over the past ten years (40 quarters), 4160.TWO's PE Ratio was at its highest in in the June 2025 quarter at 156.25. The PE Ratio was at its lowest in in the March 2024 quarter at 18.12.

Genetics Generation Advancement Corp. (4160.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Genetics Generation Advancement Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genetics Generation Advancement Corp. (4160.TWO) Average PE Ratio

How has 4160.TWO PE Ratio performed in the past?

The current PE Ratio of Genetics Generation Advancement Corp. (4160.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Genetics Generation Advancement Corp. (4160.TWO) PE Ratio vs. Peers

How is 4160.TWO’s PE Ratio compared to its peers?

Genetics Generation Advancement Corp.’s PE Ratio is greater than Kim Forest Enterprise Co., Ltd. (-6.92), greater than Lagis Enterprise Co., Ltd. (21.09), greater than Bioptik Technology Incorporation (20.27), greater than Perfect Medical Industry Co., Ltd. (22.69), greater than NaviFUS Corp. (-12.36), greater than BiOptic Inc. (61.48), greater than Acer Medical Inc. (-57.75), greater than Enimmune corporation (-6.82), greater than Tien Liang BioTech Co., Ltd. (-59.78), less than GenMont Biotech Incorporation (104.18),

Build a custom stock screener for Genetics Generation Advancement Corp. (4160.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetics Generation Advancement Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genetics Generation Advancement Corp. (4160.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genetics Generation Advancement Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.